Judge to decide abatement amounts in opioid pharmacy case

A hearing will begin Tuesday in federal court in Cleveland that will result in a judge determining how much CVSHealth, Walgreens Co. and Walmart Corp. should pay two northeast Ohio counties to help them abate the continuing opioid crisis

Via AP news wire
Tuesday 10 May 2022 12:59

How much money should CVS, Walgreens and Walmart pharmacies pay two Ohio counties in damages to help abate the effects of the opioid crisis?

That's the question in front of a federal judge in Cleveland, who will begin hearing testimony on Tuesday after a jury found the three giant pharmacy chains responsible last fall for recklessly distributing massive amounts of pain pills in Lake and Trumbull counties. It was the first time pharmacies in the U.S. have been held responsible for the opioid crisis.

Plaintiff's attorneys said before trial that each county needs about $1 billion to repair the damage caused by the flood of pills, which caused hundreds of overdose deaths.

Around 80 million prescription painkillers were dispensed in Trumbull County between 2012 and 2016 — 400 for every county resident — while 61 million pills were dispensed in Lake County during that five-year period — 265 pills for every resident.

Back in November, a jury in U.S. District Judge Dan Polster’s courtroom sided with the counties and agreed that the way the pharmacies dispensed pain medication played an outsized role in creating a public nuisance.

Now, the counties are expected to present testimony from doctors to discuss the harm suffered by those communities, the opioid crisis' impact on child welfare and other county agencies, and an abatement plan created for the counties.

“The jury sounded a bell that should be heard through all pharmacies in America,” Mark Lanier, the lead attorney for the counties, said after November’s verdict.

Across the U.S., many lawsuits filed by governments over the toll of the drugs have been resolved in recent years — most with settlements, and some with judgments or verdicts in trials. So far, drug makers, distributors and pharmacies have agreed to settlements totaling well over $40 billion, according to an Associated Press tally.

Trials are underway in courts in West Virginia, Florida and California. A decision has not yet been issued after another trial last year in West Virginia.

According to an April 25 court filing, the abatement plan created for Lake and Trumbull counties by Dr. Caleb Alexander of John Hopkins Bloomberg School of Public Health, “are reasonable and necessary to abate the public nuisance found by the jury.”

The plan focuses on prevention, treatment, recovery and “measures intended to specifically address the needs of special populations who have been uniquely affected by the opioid epidemic,” the court filing said.

Attorneys for Walgreens and Walmart argued in a court filing that the counties’ $878 million abatement plan should be limited to one year and not the minimum of five years the counties argue they need. One of the pharmacy chains’ experts has estimated the actual cost at $346 million while another expert said it’s less than $35 million, the filing said.

Defense attorneys also argued that damage caused by other entities who contributed to the public nuisance of opioid addiction should be excluded from any amounts awarded by Polster and that those costs should be limited to the pharmacies’ “appropriate share of contribution to the nuisance.”

Pharmacy chain Rite-Aid settled with the counties in early October before the start of trial. Pittsburgh-based Giant Eagle reached a settlement with the counties in late October after the trial started.

There were nearly 500,000 deaths caused by legal and illegal opioids between 2000 and 2019, according to the U.S. Centers for Disease Control.

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

Please enter a valid email
Please enter a valid email
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Please enter your first name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
Please enter your last name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
You must be over 18 years old to register
You must be over 18 years old to register
Opt-out-policy
You can opt-out at any time by signing in to your account to manage your preferences. Each email has a link to unsubscribe.

By clicking ‘Create my account’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in